Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease
Vitamin D secosteroids are intranuclear regulators of cellular growth and suppress the renin-angiotensin system. The aim of this study was to test the hypothesis that the vitamin D receptor agonist, paricalcitol (PC), either alone or with enalapril (E) (an angiotensin-converting enzyme inhibitor), r...
Guardado en:
Autores principales: | Priyanka S. Sagar, Sayanthooran Saravanabavan, Alexandra Munt, Annette T. Y. Wong, Gopala K. Rangan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90f1a31418fb4508a9399ef95e7e89f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection
por: Duplancic D, et al.
Publicado: (2013) -
Secondary hyperparathyroidism in patient with type 2 diabetes and stages 3–4 chronic kidney disease
por: Lilit V. Egshatyan, et al.
Publicado: (2018) -
Feline Polycystic Kidney Disease: An Update
por: Lorie Schirrer, et al.
Publicado: (2021) -
Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
por: Maha A. Behairy, et al.
Publicado: (2022) -
Celiac artery dissection in polycystic kidney disease
por: Koichiro Yamamoto, et al.
Publicado: (2021)